Company intelligence / Profile preview

Eyesight Ophthalmic Services

Portsmouth, New Hampshire, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Eyesight Ophthalmic Services is an active clinical care provider with a clinical research department. The organization has participated in over 90 trials, including all clinical phases, for therapies in indications like dry eye syndrome, macular degeneration, glaucoma, and LASIK techniques. Its current clinical involvement includes a Phase 3 trial for ocular hypertension/open-angle glaucoma using OTX-16 (by Ocular Therapeutix).

Therapeutic areas: Ophthalmology
Modalities: DeviceSmall moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

Clinical trial collaboration with Ocular Therapeutix (OTX-16 trial)

Beyond the preview

Go deeper on Eyesight Ophthalmic Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyesight Ophthalmic Services.

Explore the full profile